U.S. Markets open in 1 hr 21 mins

Why This Medtech Stock Could Top Its Own Bullish 3-Year Outlook

ALLISON GATLIN
Why This Medtech Stock Could Top Its Own Bullish 3-Year Outlook

Boston Scientific will likely top its own three-year guidance for a 6%-9% compound annual growth rate, analysts said Thursday as the medical technology company expands its heart devices.